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The case of 52-year-old man is presented, who had suffered from pains in his
right brachial region and in whom, upon admission to the Lower Silesia Centre
of Oncology, a tumour of 20 cm in diameter and restricted mobility was dis-
closed in the right brachial region and proximal 1/3 of his right arm. Radiograms
of his right humerus disclosed non-uniform restructuring of the osseous tissue,
dominated by osteosclerosis in the upper half of his right humerus, while in the
surrounding dift tissues of the proximal portion non-uniform shades were seen
of calcified appearance. The patient was qualified to surgical biopsy and histo-
pathological examination of the sample disclosed Chondrosarcoma G II. Follow-
ing amputation of the right upper extremity together with the scapula, the tu-
mour was subjected to histopathological and immunocytochemical examination
in the Department of Pathomorphology, Lower Silesia Centre of Oncology. In
numerous samples of the tumour dedifferentiated chondrosarcoma was diag-
nosed with a dominating component of malignant fibrous histiocytoma (MFH),
which was confirmed by detecting a high expression of alpha-1-antichymot-
rypsin (ACT) within the spindle-shaped cell component of the chondrosarcoma.
Spindle-shaped elements in dedifferentiated chondrosarcoma (DChSa) may rep-
resent patterns of fibrosarcoma, osteosarcoma or the malignant fibrohistiocy-
toma (MFH) type and they are present as if in the form of restricted fields with
no reciprocal infiltrates. Moreover, due to the worse prognosis in the case of the
MFH component in dedifferentiated chondrosarcoman as compared to that in
classical chondrosarcoma, common evaluation of the material was made by
a surgeon, radiologist and histopathologist, accompanied by a minimum panel
of immunocytochemical tests (ACT, Vimentyna, Desmina, S-100). This enabled
a final diagnosis for all tumour components to be established and prognosis to
be made regarding the further fate of the patient.
key words: dedifferentiated chondrosarcoma, dedifferentiated
sarcomas
514
Folia Morphol., 2003, Vol. 62, No. 4
INTRODUCTION
Chondrosarcoma is the second most frequently
developing malignant tumour of the bones (or third,
if multiple myeloma is also included), accounting for
around 10% of malignant bone tumours [2, 4, 9]. It
appears mainly in the 4th to 6th decade of life, al-
though around 10% patients are below 20 years of
age [2, 3, 9]. It affects males with a slightly higher
frequency than females. In more than 70% of cases
it develops in the bone of pelvis, the proximal ends
of the humerus and femur and in the bones of the
trunk [2, 9]. In a proportion of cases, the chondrosa-
rcoma component may form one of element of com-
plex tumours, consisting of, for example, osteochon-
droma. The tumour has seldom been noted in the
small bones of the hands and feet, in the mandible,
maxilla, nasal septum or laryngeal cartilages or in
the soft tissues [2, 5, 9]. Chondrosarcoma of the
bones can be subdivided into certain subtypes de-
pending on clinical, radiological and histological cri-
teria [4, 8, 9].
CASE REPORT
Patient J.R., 52 years of age felt pain in his right
shoulder from the beginning of February 2002. On
12th November, 2002 he reported to the Oncologi-
cal Outpatient Clinic, Lower Silesia Centre of Oncol-
ogy (DCO), for a surgical biopsy. Upon admission his
general condition was extremely good. Examination
of his right shoulder and proximal 1/3 of his right
arm demonstrated a tumour of poorly defined lim-
its, restricted mobility and 20 cm in diameter. In the
right armpit a mobile lymph node, 1 cm in diame-
ter, was disclosed. Radiograms of his right humerus
demonstrated a non-uniform restructuring of the
osseous tissue with prevalence of osteosclerosis in
the upper half of the right humerus. The soft tissues
of the proximal portion of the right humerus con-
tained heterogeneous shades of calciferous appear-
ance. On 14th November, 2002 an incision, made in
general anaesthesia along the long axis of the right
arm exposed a tumour, from which a biopsy was
taken for histopathological examination and the
patient was released home. Histopathological exam-
ination no. 21084–85/02 demonstrated chondrosa-
rcoma GII. The patient was re-admitted to DCO and
on 12th December 2002 and was operated on in
general anaesthesia. The right upper extremity was
amputated, together with the scapula and clavicle,
from incisions parallel to the right clavicle from the
front and along the long axis of the scapula from
the rear, following infiltration of the brachial plexus
with 2% xylocain, ligation and transsection of its el-
ements. The general condition of the patient follow-
ing surgery was good. Histopathological examina-
tion of the tumour conducted in the Department of
Pathomorphology DCO (no. 23417–19/02) using H+E
(Fig. 1) and Van Gieson staining and immunocy-
tochemical tests (ACT, anti-alpha-1-antichymot-
rypsin, vimentin, desmin, S-100, DAKO) resulted in
a diagnosis of dedifferentiated chondrosarcoma with
a dominant component of malignant fibrous histiocy-
toma. Immunocytochemical tests: ACT (+++) (Fig. 2),
vimentin (++), desmin (+), S-100 (+).
DISCUSSION
In 1971, Dahlin and Beabout [1] described for
the first time a dedifferentiated low grade chondro-
sarcoma, but recently some authors have questioned
the term, arguing that, due to the histological and
morphological structure of the tumour, it should be
termed a chondrosarcoma with a supplementary
Figure 1. Chondrosarcoma with mesenchymal component. HE;
magnification × 100.
Figure 2. Expression of ACT in mesenchymal component. Immu-
nohistochemical method; magnification × 100.
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mesenchymal component. As a rule, the tumour
appears in patients older by around 10 years than
the most common form of chondrosarcoma, which
develops in 4th-6th decade of life/ [2, 3, 9]. It is loc-
alised in the same sites and exhibits a similar multi-
annual course, with sudden acceleration of tumour
growth at the end of the patient’s life. In approxi-
mately 1/3 of cases the radiological pattern of the
tumour resembles that of a conventional chondro-
sarcoma. The tumour is, however, complex: the chon-
drosarcoma component of GI or GII differentiation
grade is accompanied by spindle cells of the high-
grade spindle cell sarcoma type, most frequently
presenting patterns of fibrosarcoma, osteosarcoma
or malignant fibrohistiocytoma [5, 7, 9]. Extremely
rarely, they may manifest traits of differentiation to
rhabdomyoblasts [2, 6, 9]. Characteristic for the tu-
mour structure is a relatively sharp delimitation of
the chondrous structure elements, which are well
differentiated from the spindle shaped cells of sar-
comatous structure. An impression is gained from
its appearance of structures positioned side by side,
instead of the infiltrations seen in chondroblastic os-
teosarcoma [5, 8, 9]. This delimitation of the two struc-
tures is significant for prognosis. In cases of dediffer-
entiated chondrosarcoma a 5-year survival amounts
to 10% and is significantly worse than in cases of chon-
droblastic osteosarcoma [9]. Metastases to the lungs
develop within 14 months of surgery [5]. Since the
radiological as well as clinical patterns are not un-
equivocal, open surgical biopsy remains the diag-
nostic procedure of choice [8]. In order to isolate
representative material for the studies, preliminary
evaluation of the material is indicated, accompanied
by analysis of radiological patterns because of the
duality of the tumour structure. In our case a single
component only was obtained during biopsy. The
final diagnosis, linked to a definitely unfavourable
prognosis, was established in preparations obtained
from the post-surgery material, isolated from many
fields.
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